News
May 15, 2020

Regenstrief and CTSI hosting virtual conference on using AI to address emergent needs in healthcare

VIEW RECORDINGS OF THE CONFERENCE

Regenstrief Institute and the Indiana Clinical and Translational Sciences Institute (CTSI) are hosting international thought leaders in artificial intelligence (AI) applications for an engaging virtual conference. “Artificial Intelligence: Applying Research and Engineering Solutions for Emergent Needs in Healthcare” will feature insights from academic, industry, government and clinical partners on June 1-3, 2020.

The conference features keynotes and panel discussions on the topics of deploying successful real-world AI solutions, future trends in healthcare AI and data science, and approaches to address challenges and leverage opportunities to deploy AI to improve healthcare delivery.

AI conference format and schedule

On June 1, Marc Overhage, M.D., PhD, former chief medical informatics officer at Cerner, will deliver a keynote presentation on AI in healthcare. He will then join a discussion panel with other experts to share experiences planning, implementing and operationalizing advanced AI methods in real-world settings. Panelists include Kathleen Unroe, M.D., MHA from Regenstrief Institute, Indiana University School of Medicine and CEO of Probari; Michael Matheny, M.D., MPH from Vanderbilt and Tennessee Valley Healthcare System’s Nashville VA Medical Center; and Joshua Vest from Regenstrief and Indiana University Richard M. Fairbanks School of Public Health at IUPUI. Regenstrief Vice President for Data and Analytics Shaun Grannis, M.D., M.S., will moderate this session.

Nigam Shah, MBBS, PhD, associate chief information officer for data science at Stanford Health Care and associate professor at Stanford University, will kick off the second day with a presentation on the future of AI in healthcare. Afterward, a panel featuring Regenstrief President and Chief Executive Officer Peter Embí, M.D.; Kenneth W. Goodman, PhD, founder and director of the University of Miami Miller School of Medicine’s Institute for Bioethics and Health Policy; and Eneida Mendonca, M.D., PhD, vice president for research development at Regenstrief will explore potential unintended consequences of AI on people’s health.

The final day will start with a keynote from Marco Antonio Gutierrez, PhD, head of Informatics Division, Heart Institute, University of Sao Paulo Medical School, Brazil. He will speak on using artificial intelligence in COVID-19 screening before joining the panel to discuss necessities and solutions in infrastructure for AI. Other experts on the panel are Mohammad (Adib) Adibuzzaman, PhD, a research scientist from the Regenstrief Center for Healthcare Engineering at Purdue University; Allen Flynn, PhD, PharmD from the University of Michigan Medical School; and Umberto Tachinardi, PhD, Regenstrief chief information officer and Indiana University Grand Challenge Precision Health Initiative chief informatics officer.

Each day’s session will take place from 11 a.m. to 2 p.m. EDT. Participants can sign up for one, two or three days. All registration options are free.

About Regenstrief Institute

Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform practice and improve the lives of patients around the globe.

Regenstrief Institute is celebrating 50 years of healthcare innovation. Sam Regenstrief, a successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.

Related News

Expanding health equity by including nursing home residents in clinical trials

INDIANAPOLIS – Clinical trials are constantly being designed and study participants enrolled to determine if medical treatments and therapies

photo background showing data, etc.

Regenstrief Institute will host collaborative conference to improve public health data

Due to previous year’s high demand, virtual attendance option added  The Public Health Informatics Program in the Center for

Study reports chlamydia and gonorrhea more likely to be treated per CDC guidelines in males, younger patients and individuals identifying as Black or multiracial

Study reports chlamydia and gonorrhea more likely to be treated per CDC guidelines in males, younger patients and individuals identifying as Black or multiracial

But significant numbers of those living with these diseases don’t receive this treatment INDIANAPOLIS – Chlamydia and gonorrhea are